Ibrahim Sacit Tuna

Ibrahim Sacit Tuna

Auto-generated profile, based on publicly available information

Ibrahim Sacit Tuna

Department of Radiology, University of Florida College of Medicine, Gainesville, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MAMehmet Sait Albayram
Mehmet Sait Albayram
GSGarrett Smith
Garrett Smith
FTFatih Tufan
Fatih Tufan
ITIbrahim Sacit Tuna
Ibrahim Sacit Tuna
MBMehmet Bostancıklıoğlu
Mehmet Bostancıklıoğlu
OAOnder Albayram
Onder Albayram
Meningeal lymphatic vessels have been described in animal studies, but limited comparable data is available in human studies. Here we show dural lymphatic structures along the dural venous sinuses in dorsal regions and along cranial nerves in the ventral regions in the human brain. 3D T2-Fluid Attenuated Inversion Recovery magnetic resonance imaging relies on internal signals of protein rich lymphatic fluid rather than contrast media and is used in the present study to visualize the major human dural lymphatic structures. Moreover we detect direct connections between lymphatic fluid channels along the cranial nerves and vascular structures and the cervical lymph nodes. We also identify age-related cervical lymph node atrophy and thickening of lymphatics channels in both dorsal and ventral regions, findings which reflect the reduced lymphatic output of the aged brain.

1 December 2017 in Human Gene Therapy Clinical Development
Verified
Journal Article
Closed access
MCManuela Corti
Manuela Corti
CLCristina Liberati
Cristina Liberati
BSBarbara K. Smith
Barbara K. Smith
LLLee Ann Lawson
Lee Ann Lawson
ITIbrahim S. Tuna
Ibrahim S. Tuna
BBBarry J. Byrne
Barry J. Byrne
A first-in-human trial of diaphragmatic gene therapy (AAV1-CMV-GAA) to treat respiratory and neural dysfunction in early-onset Pompe disease was conducted. The primary objective of this study was to assess the safety of rAAV1-CMV-hGAA vector delivered to the diaphragm muscle of Pompe disease subjects with ventilatory insufficiency. Safety was assessed by measurement of change in serum chemistries and hematology, urinalysis, and immune response to GAA and AAV, as well as change in level of health. The data demonstrate that the AAV treatment was safe and there were no adverse events related to the study agent. Adverse events related to the study procedure were observed in subjects with lower baseline neuromuscular function. All adverse events were resolved before the end of the study, except for one severe adverse event determined not to be related to either the study agent or the study procedure. In addition, an anti-capsid and anti-transgene antibody response was observed in all subjects who received rAAV1-CMV-hGAA, except for subjects who received concomitant immunomodulation to manage reaction to enzyme replacement therapy, as per their standard of care. This observation is significant for future gene therapy studies and serves to establish a clinically relevant approach to blocking immune responses to both the AAV capsid protein and transgene product.

3 June 2008 in Annals of Internal Medicine
Verified
Journal Article
Closed access
FTFatih Tanriverdi
Fatih Tanriverdi
KUKursad Unluhizarci
Kursad Unluhizarci
IKIsmail Kocyigit
Ismail Kocyigit
ITIbrahim S. Tuna
Ibrahim S. Tuna
ZKZuleyha Karaca
Zuleyha Karaca
TITuna Is
Tuna Is
Read the full review for this F1000Prime recommended article: Brief communication: pituitary volume and function in competing and retired male boxers.

1 November 2011 in European Journal of Radiology
Verified
Journal Article
Closed access
AYAli Yikilmaz
Ali Yikilmaz
OKOkkes Ibrahim Karahan
Okkes Ibrahim Karahan
SSSerkan Senol
Serkan Senol
ITIbrahim Sacit Tuna
Ibrahim Sacit Tuna
HAHizir Yakup Akyildiz
Hizir Yakup Akyildiz

1 January 2018 in NeuroImage: Clinical
Verified
Journal Article
Open access
EMErik Middlebrooks
Erik Middlebrooks
ITIbrahim S. Tuna
Ibrahim S. Tuna
LALeonardo Almeida
Leonardo Almeida
SGSanjeet S. Grewal
Sanjeet S. Grewal
JWJoshua Wong
Joshua Wong
VHVanessa M. Holanda
Vanessa M. Holanda
Traditional targeting methods for thalamic deep brain stimulation (DBS) performed to address tremor have predominantly relied on indirect atlas-based methods that focus on the ventral intermediate nucleus despite known variability in thalamic functional anatomy. Improvements in preoperative targeting may help maximize outcomes and reduce thalamic DBS-related complications. In this study, we evaluated the ability of thalamic parcellation with structural connectivity-based segmentation (SCBS) to predict tremor improvement following thalamic DBS. In this retrospective analysis of 40 patients with essential tremor, hard segmentation of the thalamus was performed by using probabilistic tractography to assess structural connectivity to 7 cortical targets. The volume of tissue activated (VTA) was modeled in each patient on the basis of the DBS settings. The volume of overlap between the VTA and the 7 thalamic segments was determined and correlated with changes in preoperative and postoperative Fahn-Tolosa-Marin Tremor Rating Scale (TRS) scores by using multivariable linear regression models. A significant association was observed between greater VTA in the supplementary motor area (SMA) and premotor cortex (PMC) thalamic segment and greater improvement in TRS score when considering both the raw change (P = .001) and percentage change (P = .011). In contrast, no association was observed between change in TRS score and VTA in the primary motor cortex thalamic segment (P ≥ .19). Our data suggest that greater VTA in the thalamic SMA/PMC segment during thalamic DBS was associated with significant improvement in TRS score in patients with tremor. These findings support the potential role of thalamic SCBS as an independent predictor of tremor improvement in patients who receive thalamic DBS.

26 April 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
EMErik Middlebrooks
Erik Middlebrooks
ITI.S. Tuna
I.S. Tuna
SGSanjeet S. Grewal
Sanjeet S. Grewal
LAL. Almeida
L. Almeida
MHM.G. Heckman
M.G. Heckman
VHV.M. Holanda
V.M. Holanda
BACKGROUND AND PURPOSE: Although globus pallidus internus deep brain stimulation is a widely accepted treatment for Parkinson disease, there is persistent variability in outcomes that is not yet fully understood. In this pilot study, we aimed to investigate the potential role of globus pallidus internus segmentation using probabilistic tractography as a supplement to traditional targeting methods. MATERIALS AND METHODS: Eleven patients undergoing globus pallidus internus deep brain stimulation were included in this retrospective analysis. Using multidirection diffusion-weighted MR imaging, we performed probabilistic tractography at all individual globus pallidus internus voxels. Each globus pallidus internus voxel was then assigned to the 1 ROI with the greatest number of propagated paths. On the basis of deep brain stimulation programming settings, the volume of tissue activated was generated for each patient using a finite element method solution. For each patient, the volume of tissue activated within each of the 10 segmented globus pallidus internus regions was calculated and examined for association with a change in the Unified Parkinson Disease Rating Scale, Part III score before and after treatment. RESULTS: Increasing volume of tissue activated was most strongly correlated with a change in the Unified Parkinson Disease Rating Scale, Part III score for the primary motor region (Spearman r = 0.74, P = .010), followed by the supplementary motor area/premotor cortex (Spearman r = 0.47, P = .15). CONCLUSIONS: In this pilot study, we assessed a novel method of segmentation of the globus pallidus internus based on probabilistic tractography as a supplement to traditional targeting methods. Our results suggest that our method may be an independent predictor of deep brain stimulation outcome, and evaluation of a larger cohort or prospective study is warranted to validate these findings.